All The Claims

1. A method of restricting access to a device, comprising:
obtaining a passphrase for a user;
obtaining access credentials for the user;
obtaining a PIN value for the user;
one-way encrypting at least the access credentials and the PIN using a secret key provided with the device;
allowing access to the device if the result of one-way encrypting equals the passphrase; and
denying access to the device if the result of one-way encrypting does not equal the passphrase.
2. A method, according to claim 1, wherein the device is a storage device.
3. A method, according to claim 1, wherein the access credentials include a username that identifies the user and a role for the user.
4. A method, according to claim 1, wherein the access credentials include a time period for which access is allowed.
5. A method, according to claim 4, further comprising:
after allowing access, subsequently revoking access in response to the current date and time being greater than the time period for which access is allowed.
6. A method, according to claim 1, further comprising:
obtaining timedate data indicative of a current date and time; and
one-way encrypting the timedate data along with the access credentials and the PIN using the secret key.
7. A method, according to claim 6, further comprising:
after allowing access, subsequently revoking access in response to the current date and time being greater than the time period for which access is allowed.
8. A method, according to claim 1, wherein obtaining the passphrase includes the user presenting at least one of: a smartcard, a memory stick, a floppy disk, and a CD.
9. A method, according to claim 1, wherein obtaining the passphrase includes the user typing in the passphrase.
10. A method, according to claim 1, further comprising:
obtaining a device ID indicative of the device being accessed; and
one-way encrypting the device ID along with the access credentials and the PIN using the secret key.
11. A method, according to claim 1, wherein the secret key is provided at the device in tamper-proof hardware.
12. A computer readable medium having computer executable instructions for performing the steps recited in claim 1.
13. A method of constructing a passphrase for a user to gain access to a device, comprising:
obtaining a username that identifies the user;
obtaining a PIN for the user;
obtaining an expected time of access for the device;
obtaining an identifier that identifies the device; and
using a secret key to one-way encrypt the username, the PIN, the expected time of access, and the identifier to provide the passphrase.
14. A method, according to claim 13, wherein the device is a storage device.
15. A method, according to claim 13, further comprising:
storing the passphrase in a computer-readable medium.
16. A method, according to claim 15, wherein the computer readable medium is one of: a smartcard, a memory stick, a floppy disk, and a CD.
17. A computer readable medium having computer executable instructions for performing the steps recited in claim 13.
18. A computer storage device, comprising:
a plurality of disk drives;
a plurality of disk adapters coupled to the disk drives;
a memory coupled to the plurality of disk adapters;
a plurality of host adapters, coupled to the disk adapters and the memory, that communicate with host computers to send and receive data to and from the disk drives; and
a service processor director, coupled to the memory, that restricts access to the storage device by obtaining a passphrase for a user, obtaining access credentials for the user, obtaining a PIN value for the user, one-way encrypting at least the access credentials and the PIN using a secret key provided with the storage device, allowing access to the storage device if the result of one-way encrypting equals the passphrase, and denying access to the storage device if the result of one-way encrypting does not equal the passphrase.
19. A storage device, according to claim 18, wherein the access credentials include a username that identifies the user and a role for the user.
20. A storage device, according to claim 19, wherein the access credentials include a time period for which access is allowed.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

We claim:

1. A document type definition (DTD) comprising metadata for at least two types of digital assets selected from the group consisting of photographs, audio recordings, video recordings, movies, graphics, and text documents.
2. The document type definition of claim 1 wherein said document type definition is encoded in extensible markup language (XML).
3. The document type definition of claim 1 comprising metadata for photographs and audio recordings.
4. The document type definition of claim 1 comprising metadata for photographs and video recordings.
5. The document type definition of claim 1 comprising metadata for photographs, audio recordings, and video recordings.
6. The document type definition of claim 1 comprising metadata for photographs, audio recordings, and movies.
7. The document type definition of claim 1 comprising metadata for photographs and further comprising a plurality of metadata attributes for said photograph metadata, said photograph metadata attributes comprising:
a definition for blackwhite;
a definition for color; and
a definition for caption.
8. The document type definition of claim 1 comprising metadata for audio recordings and further comprising a plurality of metadata attributes for said audio metadata, said audio metadata attributes comprising:
a definition for music;
a definition for track title; and
a definition for duration.
9. The document type definition of claim 1 comprising metadata for audio and further comprising a plurality of metadata attributes for said audio metadata, said audio metadata attributes comprising:
a definition for compact disc (CD) number; and
a definition for CD title.
10. The document type definition of claim 1 comprising metadata for movies and further comprising a plurality of metadata attributes for said movie metadata, said movie metadata attributes comprising:
a definition for title; and
a definition for version.
11. The document type definition of claim 1 comprising metadata for movies and further comprising a plurality of metadata attributes for said movie metadata, said movie metadata attributes comprising:
a definition for rating;
a definition for minutes; and
a definition for release date.
12. The document type definition of claim 1 comprising metadata for movies and further comprising a plurality of metadata attributes for said movie metadata, said movie metadata attributes comprising:
a definition for run time;
a definition for color; and
a definition for synopsis.
13. The document type definition of claim 1 comprising metadata for movies and further comprising a plurality of metadata attributes for said movie metadata, said movie metadata attributes comprising:
a definition for director; and
a definition for cast.
14. A document type definition (DTD) comprising metadata for at least three types of digital assets selected from the group consisting of photographs, audio recordings, video recordings, movies, graphics, and text documents.
15. A document type definition (DTD) comprising metadata for photographic digital assets, audio digital assets, promo digital assets, and voiceover digital assets.
16. A document type definition (DTD) comprising:
digital content selected from the group consisting of digitally encoded asset data, a link to a file containing asset data, and a reference to a location where asset data is digitally stored; and
metadata for at least three types of digital assets selected from the group consisting of photographs, audio recordings, video recordings, movies, graphics, promos voiceovers, and text documents.
17. A database comprising:
a first record having a plurality of fields identifying a photograph;
a second record having a plurality of fields identifying a motion picture movie; and
a third record having a plurality of fields identifying a musical recording.
18. The database of claim 17 wherein said first record comprises a field identifying the photographer.
19. The database of claim 17 wherein said second record comprises a field identifying the title of said movie.
20. The database of claim 17 wherein said third record comprises a field identifying the composer of said musical recording.
21. A database comprising:
a first record having a plurality of fields identifying a photograph;
a second record having a plurality of fields identifying a movie;
a third record having a plurality of fields identifying an audio recording; and
a fourth record having a plurality of fields identifying a voiceover.
22. A database comprising:
a first record having a plurality of fields identifying a photograph;
a second record having a plurality of fields identifying a movie;
a third record having a plurality of fields identifying an audio recording;
a fourth record having a plurality of fields identifying a voiceover; and
a fifth record having a plurality of fields identifying a promo.
23. A digital asset library comprising:
a database comprising a plurality of records, one said record identifying a photograph, a second said record identifying a video recording, and a third said record identifying an audio recording; and
a document type definition (DTD) comprising definitions for photographs, video recordings, and audio recordings, said DTD corresponding to said database records.
24. A digital asset library comprising:
a database comprising a plurality of records, one said record identifying a photograph, a second said record identifying a video recording, and a third said record identifying an audio recording;
a document type definition (DTD) comprising definitions for photographs, video recordings, and audio recordings, said DTD corresponding to said database records; and
digital content comprising a photograph, a video recording, and an audio recording.
25. A digital asset library stored in a computer system, said library comprising:
a database comprising a plurality of records, said records identifying at least two types of digital assets selected from the group consisting of still images, audio recordings, video recordings, movies, graphics, voice-overs, promos, and text documents;
a document type definition (DTD) comprising definitions for said at least two types of digital assets, said DTD corresponding to said database records; and
digital content of said at least two types of digital assets.
26. A method of retrieving digital assets from a single digital asset library, said digital assets comprising at least three different types of digital assets selected from the group consisting of still images, video recordings, audio recordings, graphics, promos, voiceovers, and text, said method comprising:
receiving a request for at least one digital asset, said request comprising criteria to which said at least one digital asset is to conform;
accessing a document type definition (DTD) of sail digital asset library, said DTD defining data elements for at least three different types of digital assets selected from the group consisting of still images, video recordings, audio recordings, graphics, promos, voiceovers, and text;
searching a database of said digital asset library for said at least one digital asset, said database comprising a plurality of records identifying digital assets of at least three different types selected from the group consisting of still images, video recordings, audio recordings, graphics, promos, voiceovers, and text; and
returning a list of at least one digital asset conforming to said criteria.
27. The method of claim 26 wherein said criteria comprises a keyword.
28. The method of claim 26 wherein said criteria comprises a product ID and a version ID.
29. The method of claim 26 wherein said returning a list comprises returning a list of at least three digital assets each conforming to said criteria, each said asset being of a different asset type selected from the group consisting of still images, video recordings, audio Recordings, graphics, promos, voiceovers, and text.
30. The method of claim 26 further comprising:
receiving a request for a copy of said at least one digital asset conforming to said criteria;
accessing said at least one digital asset stored in a computer memory device of said digital asset library; and
creating a copy of said at least one digital asset in compliance with said request for a copy.

1. An isolated polynucleotide encoding a polypeptide selected from the group consisting of:
a) a polypeptide comprising the sequence of SEQ ID No. 3;
b) a polypeptide comprising an amino acid sequence at least 80% identical over the full length to the amino acid sequence of SEQ ID No. 3 and
c) a polypeptide comprising a fragment of at least 10 consecutive amino acids of SEQ ID No. 3;
wherein said isolated polypeptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID NO: 3, antimicrobial activity, and cytotoxic activity.
2. An isolated polynucleotide encoding a polypeptide comprising:
a) a signal peptide comprising the sequence of SEQ ID No. 4;
b) a proregion comprising the sequence of SEQ ID No. 5;
c) a mature peptide comprising the sequence SEQ ID No. 6;
d) a polypeptide comprising an amino acid sequence at least 90% identical over the full length to the amino acid sequence of SEQ ID No. 4, SEQ ID No. 5, or SEQ ID No. 6; or
e) a fragment comprising at least 10 consecutive amino acids of SEQ ID NO: 4, SEQ ID NO. 5, or SEQ ID NO. 6;
wherein said signal peptide causes intra- or extracellular secretion of a polypeptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 4;
wherein said proregion inactivates the precursor form of the defensin molecule andor provides a support for the acquisition of the active conformation of the mature peptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 5;
wherein said mature peptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 6, antimicrobial activity, and cytotoxic activity;
wherein said fragment of SEQ ID No. 4 causes intra- or extracellular secretion of a polypeptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 4;
wherein said fragment of SEQ ID No. 5 inactivates the precursor form of the defensin molecule andor provides a support for the acquisition of the active conformation of the mature peptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 5; and
wherein said fragment of SEQ ID No. 6 has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO 6, antimicrobial activity, and cytotoxic activity.
3. An isolated polynucleotide encoding a polypeptide selected from the group consisting of:
a) a polypeptide comprising the sequence of SEQ ID No. 6;
b) a polypeptide comprising an amino acid sequence at least 80% identical over the full length to the amino acid sequence of SEQ ID No. 6 and
c) a polypeptide comprising a fragment of at least 10 consecutive amino acids of the sequence of SEQ ID No. 6
wherein said isolated polypeptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID NO: 3 or SEQ ID NO: 6, antimicrobial activity, and cytotoxic activity.
4. The isolated polynucleotide according to claim 1, wherein said polynucleotide encodes a polypeptide fragment comprising at least 15 consecutive amino acids.
5. The isolated polynucleotide according to claim 1, wherein said polynucleotide encodes a polypeptide comprising the sequence of SEQ ID No. 3.
6. The isolated polynucleotide according to claim 1, wherein said polynucleotide encodes a polypeptide comprising an amino acid sequence at least 80% identical over the full length to the amino acid sequence of SEQ ID No. 3.
7. The isolated polynucleotide according to claim 1, wherein said polynucleotide encodes a polypeptide comprising a fragment of at least 10 consecutive amino acids of the polypeptide of SEQ ID No. 3.
8. The isolated polynucleotide according to claim 2, wherein said polynucleotide encodes a polypeptide comprising a signal peptide comprising the sequence of SEQ ID No. 4.
9. The isolated polynucleotide according to claim 2, wherein said polynucleotide encodes a polypeptide comprising a proregion comprising the sequence of SEQ ID No. 5.
10. The isolated polynucleotide according to claim 2, wherein said polynucleotide encodes a polypeptide comprising a mature peptide comprising the sequence of SEQ ID No. 6.
11. The isolated polynucleotide according to claim 2, wherein said polynucleotide encodes a polypeptide comprising an amino acid sequence at least 90% identical over the full length to the amino acid sequence of SEQ ID No. 4, SEQ ID No. 5, or SEQ ID No. 6.
12. The isolated polynucleotide according to claim 2, wherein said polynucleotide encodes a polypeptide comprising a fragment of at least 10 consecutive amino acids of the signal peptide comprising the sequence of SEQ ID No. 4.
13. The isolated polynucleotide according to claim 2, wherein said polynucleotide encodes a polypeptide comprising a fragment of at least 10 consecutive amino acids of a proregion comprising the sequence of SEQ ID No. 5.
14. The isolated polynucleotide according to claim 2, wherein said polynucleotide encodes a polypeptide comprising a fragment of at least 10 consecutive amino acids of a mature peptide comprising the sequence of SEQ ID No. 6.
15. The isolated polynucleotide according to claim 3, wherein said polynucleotide encodes a polypeptide comprising the sequence of SEQ ID No. 6.
16. The isolated polynucleotide according to claim 3, wherein said polynucleotide encodes a polypeptide comprising an amino acid sequence at least 80% identical over the full length to the amino acid sequence of SEQ ID No. 6.
17. The isolated polynucleotide according to claim 3, wherein said polynucleotide encodes a polypeptide comprising a fragment of at least 10 consecutive amino acids of the sequence of SEQ ID No. 6.
18. The isolated polynucleotide according to claim 3, wherein said polynucleotide encodes a polypeptide comprising at least 15 consecutive amino acids.
19. The isolated polynucleotide according to claim 2, wherein said polynucleotide encodes a polypeptide comprising at least 15 consecutive amino acids.
20. The isolated polynucleotide according to claim 11, wherein said polynucleotide encodes a polypeptide having an amino acid sequence at least 90% identical over the full length to the amino acid sequence of SEQ ID No. 4.
21. The isolated polynucleotide according to claim 1, wherein said polynucleotide encodes a polypeptide having an amino acid sequence at least 90% identical over the full length to the amino acid sequence of SEQ ID No. 5.
22. The isolated polynucleotide according to claim 11, wherein said polynucleotide encodes a polypeptide having an amino acid sequence at least 90% identical over the full length to the amino acid sequence of SEQ ID No. 6.
23. A vector comprising a polynucleotide encoding a polypeptide selected from the group consisting of:
a) a polypeptide comprising the sequence of SEQ ID No. 3;
b) a polypeptide comprising an amino acid sequence at least 80% identical over the full length to the amino acid sequence of SEQ ID No. 3 and
c) a polypeptide comprising a fragment of at least 10 consecutive amino acids of SEQ ID No. 3;
wherein said isolated polypeptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID NO: 3, antimicrobial activity, and cytotoxic activity.
24. A vector comprising a polynucleotide encoding a polypeptide comprising:
a) a signal peptide comprising the sequence of SEQ ID No. 4;
b) a proregion comprising the sequence of SEQ ID No. 5;
c) a mature peptide comprising the sequence SEQ ID No. 6;
d) a polypeptide comprising an amino acid sequence at least 90% identical over the full length to the amino acid sequence of SEQ ID No. 4, SEQ ID No. 5, or SEQ ID No. 6; or
e) a fragment comprising at least 10 consecutive amino acids of SEQ ID NO: 4, SEQ ID NO. 5, or SEQ ID NO. 6;
wherein said signal peptide causes intra- or extracellular secretion of a polypeptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 4;
wherein said proregion inactivates the precursor form of the defensin molecule andor provides a support for the acquisition of the active conformation of the mature peptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 5;
wherein said mature peptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 6, antimicrobial activity, and cytotoxic activity;
wherein said fragment of SEQ ID No. 4 causes intra- or extracellular secretion of a polypeptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 4;
wherein said fragment of SEQ ID No. 5 inactivates the precursor form of the defensin molecule andor provides a support for the acquisition of the active conformation of the mature peptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 5; and
wherein said fragment of SEQ ID No. 6 has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO 6, antimicrobial activity, and cytotoxic activity.
25. A vector comprising a polynucleotide encoding a polypeptide selected from the group consisting of:
a) a polypeptide comprising the sequence of SEQ ID No. 6;
b) a polypeptide comprising an amino acid sequence at least 80% identical over the full length to the amino acid sequence of SEQ ID No. 6 and
c) a polypeptide comprising a fragment of at least 10 consecutive amino acids of the sequence of SEQ ID No. 6;
wherein said isolated polypeptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID NO: 3 or SEQ ID NO: 6, antimicrobial activity, and cytotoxic activity.
26. The vector according to claim 23, further comprising elements ensuring the expression of said polynucleotide in a host cell.
27. The vector according to claim 24, further comprising elements ensuring the expression of said polynucleotide in a host cell.
28. The vector according to claim 25, further comprising elements ensuring the expression of said polynucleotide in a host cell.
29. A host cell transformed with a vector comprising a polynucleotide encoding a polypeptide selected from the group consisting of:
a) a polypeptide comprising the sequence of SEQ ID No. 3;
b) a polypeptide comprising an amino acid sequence at least 80% identical over the full length to the amino acid sequence of SEQ ID No. 3 and
c) a polypeptide comprising a fragment of at least 10 consecutive amino acids of SEQ ID No. 3;
wherein said isolated polypeptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID NO: 3, antimicrobial activity, and cytotoxic activity.
30. A host cell transformed with a vector comprising a polynucleotide encoding a polypeptide comprising:
a) a signal peptide comprising the sequence of SEQ ID No. 4;
b) a proregion comprising the sequence of SEQ ID No. 5;
c) a mature peptide comprising the sequence SEQ ID No. 6;
d) a polypeptide comprising an amino acid sequence at least 90% identical over the full length to the amino acid sequence of SEQ ID No. 4, SEQ ID No. 5, or SEQ ID No. 6; or
e) a fragment comprising at least 10 consecutive amino acids of SEQ ID NO: 4, SEQ ID NO. 5, or SEQ ID NO. 6;
wherein said signal peptide causes intra- or extracellular secretion of a polypeptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 4;
wherein said proregion inactivates the precursor form of the defensin molecule andor provides a support for the acquisition of the active conformation of the mature peptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 5;
wherein said mature peptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 6, antimicrobial activity, and cytotoxic activity;
wherein said fragment of SEQ ID No. 4 causes intra- or extracellular secretion of a polypeptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 4;
wherein said fragment of SEQ ID No. 5 inactivates the precursor form of the defensin molecule andor provides a support for the acquisition of the active conformation of the mature peptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 5; and
wherein said fragment of SEQ ID No. 6 has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO 6, antimicrobial activity, and cytotoxic activity.
31. A host cell comprising a vector comprising a polynucleotide encoding a polypeptide selected from the group consisting of:
a) a polypeptide comprising the sequence of SEQ ID No. 6;
b) a polypeptide comprising an amino acid sequence at least 80% identical over the full length to the amino acid sequence of SEQ ID No. 6; and
c) a polypeptide comprising a fragment of at least 10 consecutive amino acids of the sequence of SEQ ID No. 6
wherein said isolated polypeptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID NO: 3 or SEQ ID NO: 6, antimicrobial activity, and cytotoxic activity.
32. A method of producing a polypeptide comprising culturing a host cell transformed with the vector comprising the polynucleotide encoding a polypeptide selected from the group consisting of:
a) a polypeptide comprising the sequence of SEQ ID No. 3;
b) a polypeptide comprising an amino acid sequence at least 80% identical over the full length to the amino acid sequence of SEQ ID No. 3 and
c) a polypeptide comprising a fragment of at least 10 consecutive amino acids of SEQ ID No. 3;
wherein said isolated polypeptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID NO: 3, antimicrobial activity, and cytotoxic activity.
33. A method of producing a polypeptide comprising culturing a host cell transformed with a vector comprising the polynucleotide encoding a polypeptide comprising:
a) a signal peptide comprising the sequence of SEQ ID No. 4;
b) a proregion comprising the sequence of SEQ ID No. 5;
c) a mature peptide comprising the sequence SEQ ID No. 6;
d) a polypeptide comprising an amino acid sequence at least 90% identical over the full length to the amino acid sequence of SEQ ID No. 4, SEQ ID No. 5, or SEQ ID No. 6; or
e) a fragment comprising at least 10 consecutive amino acids of SEQ ID NO: 4, SEQ ID NO. 5, or SEQ ID NO. 6;
wherein said signal peptide causes intra- or extracellular secretion of a polypeptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 4;
wherein said proregion inactivates the precursor form of the defensin molecule andor provides a support for the acquisition of the active conformation of the mature peptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 5;
wherein said mature peptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 6, antimicrobial activity, and cytotoxic activity;
wherein said fragment of SEQ ID No. 4 causes intra- or extracellular secretion of a polypeptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 4;
wherein said fragment of SEQ ID No. 5 inactivates the precursor form of the defensin molecule andor provides a support for the acquisition of the active conformation of the mature peptide andor is recognized by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO: 5; and
wherein said fragment of SEQ ID No. 6 has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID No. 3 or SEQ ID NO 6, antimicrobial activity, and cytotoxic activity.
34. A method of producing a polypeptide comprising culturing a host cell transformed with a vector comprising a polynucleotide encoding a polypeptide selected from the group consisting of:
a) a polypeptide comprising the sequence of SEQ ID No. 6;
b) a polypeptide comprising an amino acid sequence at least 80% identical over the full length to the amino acid sequence of SEQ ID No. 6 and
c) a polypeptide comprising a fragment of at least 10 consecutive amino acids of the sequence of SEQ ID No. 6
wherein said isolated polypeptide has at least one biological activity selected from the group consisting of recognition by an antibody specific for the polypeptide of SEQ ID NO: 3 or SEQ ID NO: 6, antimicrobial activity, and cytotoxic activity.
35. The transformed host cell according to claim 29, wherein said vector further comprises elements ensuring the expression of said polynucleotide in said host cell.
36. The transformed host cell according to claim 30, wherein said vector further comprises elements ensuring the expression of said polynucleotide in said host cell.
37. The transformed host cell according to claim 31, wherein said vector further comprises elements ensuring the expression of said polynucleotide in said host cell.
38. The method according to claim 32, wherein said vector further comprises elements ensuring the expression of said polynucleotide in said host cell.
39. The method according to claim 33, wherein said vector further comprises elements ensuring the expression of said polynucleotide in said host cell.
40. The method according to claim 34, wherein said vector further comprises elements ensuring the expression of said polynucleotide in said host cell.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A magnetic resonance imaging permanent magnet system comprising:
a generally C-shaped yoke (1) formed from a single piece of cast steel;
said yoke (1) having a vertical post (24), said vertical post having two ends, said yoke further comprising diagonal sections (20, 22) extending from each end of said vertical post, said diagonal sections having angled inside and outside faces, said inside faces defining an angle of approximately 45 degrees in relation to said vertical post, and said yoke further comprising substantially horizontal arms (10, 12, 16; and 10, 14, 18) extending from each of said diagonal sections;
a pair of poles (2) supported on said horizontal arms (10), each of said poles (2) being made substantially of permanently magnetized NdFeB and having respective pole faces which are opposed to one another and in a spaced relation to define an imaging volume between said pole faces;
said vertical post having a portion of reduced width at its medial extent, with said vertical post (24) being wider at an intersection thereof with said diagonal sections (20,22);
the ends of said horizontal arms (12, 14) adjacent said imaging volume being beveled inward on the opposite side from the imaging volume;
a substantially flat permanently magnetized NdFeB plate (3) mounted on the surface of the inside face of each of said diagonal sections (20, 22) in face to face relationship with said inside face toward said imaging volume, said inside face and said plate (3) defining an angle of approximately 45 degrees in relation to said horizontal post, said plates (3) being poled to oppose leakage flux between the nearest pole (2) and the post, and to maintain the flux both in the imaging volume and in the vertical post;
a pair of composite pole plates (4), one pole plate mounted on each of said pole faces on either side of the imaging volume, each of said pole plates (4) comprising a tape wound laminated thin sheet of high resistivity silicon steel with an insulating adhesive between each layer of the tape, and wherein said laminated sheet is segmented into a plurality of wedge-shaped elements, with said wedge-shaped elements being formed into a circular disk shape with an insulating adhesive between the respective wedge-shaped elements; and
a pole ring (5) mounted on each of said pole plates (4).
2. A magnet system as in claim 1 wherein said imaging volume has a vertical extent of at least 0.47 m, with the diameter of said poles (2) being between 1.0 m and 1.2 m, and the thickness of said pole plates (4) being between 45 mm and 60 mm.
3. A magnet system as in claim 2 wherein the vertical post (24) has a vertical extent between 1.8 m and 1.9 m, with the width of said diagonal sections being between 1.2 m and 1.4 m, and with the depth of said vertical post (24) being between 1.7 m and 1.9 m.